Skip to main content

Table 1 Observational studies using ECMO in adult septic shock, modified and extended according to Riera [13] et al.

From: Septic shock: ECMO beyond ARDS? Introducing the Simon two-stage protocol when randomisation is considered unethical

Study

N

Sites of infection

%

ECMO

configuration

Hospital

Survival

%

Brechot et al. [14]

14

Pneumonia bacterial 79

Abdomen 14,3

Peripheral va 36%

Switch to vv

71

Huang et al. [15]

52

Pneumonia 48

Abdomen 23

Urinary tract 9,6

Peripheral va

15

Cheng et al. [16]

108

Pneumonia bacterial 40

Myocarditis 25

Primary bloodstream 19,4

Peripheral va 78,7

Peripheral vv 21,3

28,7

Park et al. [17]

32

Pneumonia bacterial 34,4

Abdomen 21,9

Urinary tract 12,5

Peripheral va

21,9

Cheng et al. [18]

151

Pneumonia 50,3

Myocarditis 19,9

Bloodstream 14,6

Abdomen 7,6

Peripheral va 66,9

vv 33,1

29,8

Von Bahr et al. [19]

255

Pneumonia bacterial 53

Pneumonia viral 12,5

vv 68

switch to va

peripheral 21

switch to vv 16

64

Takauji et al. [20]

40

Pneumonia 62,5

Abdomen 20

Urinary tract 7,5

vv

47,5

Yeo et al. [21]

8

Pneumonia n = 5

Extra-pulmonary n = 3

vva

50

Choi et al. [22]

28

Pulmonary 46,4

Abdomen 14,3

Genitourinary 7,1

Skin or soft tissue 14,3

Cardiovascular 7,1

Central nerve system 3,6

Catheter-induced 3,6

Other 3,6

vv, va, vva

35,7

Ro et al. [23]

71

Pneumonia 70

Abdomen 11

Urinary tract 5

Other 14

va

7

Vogel et al. [24]

12

Septic cardiomyopathy n = 12

vva

75

Banjas et al. [25]

19

Pneumonia 53

Abdomen 42

Soft tissue 5

vv, va, vva

42

Falk et al. [26]

37

Lung n = 21

Gut n = 2

Pyelonephritis n = 4

Fasciitis n = 4

Urine n = 1

Blood n = 4

Myocarditis n = 1

vv, va

Distributive

shock 70,6

Cytotoxic

Cardiac failure

90,0